CIK 0001082554
- Large accelerated filer
UNITED THERAPEUTICS Corp
Sign in to watch- Ticker
- UTHR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 521984749
- Phone
- +1 301-608-9292
- Business address
- 1000 SPRING ST, SILVER SPRING, MD, 20910
- 4 Open-market sale Director sold 2,000 shares at an average $539.17 ($1,078,332)
- 4 Planned sale Chairperson & CEO sold 9,500 shares at an average $529.36 ($5,028,919)
- 4 Planned sale CFO AND TREASURER sold 10,000 shares at an average $527.48 ($5,274,802)
- 4 Planned sale Chairperson & CEO sold 9,500 shares at an average $527.01 ($5,006,558)
- 4 Planned sale Director sold 200 shares at $530.00 ($106,000)
- 4 Planned sale Chairperson & CEO sold 9,500 shares at an average $524.99 ($4,987,387)
- 4 Planned sale Chairperson & CEO sold 9,500 shares at an average $528.83 ($5,023,884)
- 4 Planned sale Chairperson & CEO sold 9,500 shares at an average $529.59 ($5,031,118)
- 4 Planned sale EVP & GENERAL COUNSEL sold 8,300 shares at an average $529.95 ($4,398,611)
- 4 Planned sale Chairperson & CEO sold 9,500 shares at an average $536.75 ($5,099,104)
- 4 Planned sale Chairperson & CEO sold 9,500 shares at an average $533.90 ($5,072,019)
- 4 Shares withheld for taxes PRESIDENT AND COO gave up 14,706 shares (to pay taxes)
- 4 Shares withheld for taxes CFO AND TREASURER gave up 8,786 shares (to pay taxes)
- 4 Shares withheld for taxes EVP & GENERAL COUNSEL gave up 8,363 shares (to pay taxes)
- 4 Shares withheld for taxes Chairperson & CEO gave up 29,196 shares (to pay taxes)
- 4 Planned sale Director sold 45 shares at $533.51 ($24,008)
- 4 Planned sale Director sold 200 shares at $535.44 ($107,088)
- 4 Planned sale Chairperson & CEO sold 9,500 shares at an average $538.00 ($5,110,967)
- 4 Planned sale Chairperson & CEO sold 9,500 shares at an average $537.81 ($5,109,148)
- 4 Planned sale Chairperson & CEO sold 9,500 shares at an average $539.54 ($5,125,647)
Page 13 of 164 · 3,272 filings